HMSL to begin Hemolink trial

Hemosol (HMSL; TSE:HML) said it received approval from the FDA to begin a Phase II trial of its Hemolink crosslinked hemoglobin 10% solution in 180 patients undergoing primary cardiac bypass grafting ...